Subscribe

Subscribe to Our Newsletter

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

Newsdesk

402 Posts

Biotech Market Rebound: Key Executive Moves, AstraZeneca's Drug Setback, and Expedition Funding News post image
Investment Trends biotech healthcare-funding pharmaceutical

Biotech Market Rebound: Key Executive Moves, AstraZeneca's Drug Setback, and Expedition Funding News

by Newsdesk
Natco Pharma Secures Landmark Patent Victory for Generic Risdiplam, Boosting Rare Disease Access in India post image
Regulatory Policy regulatory rare-diseases drug-pricing

Natco Pharma Secures Landmark Patent Victory for Generic Risdiplam, Boosting Rare Disease Access in India

by Newsdesk
FDA Approves Regeneron's Libtayo for Adjuvant Treatment of High-Risk Cutaneous Squamous Cell Carcinoma post image
FDA Approvals fda-approval oncology clinical-trials

FDA Approves Regeneron's Libtayo for Adjuvant Treatment of High-Risk Cutaneous Squamous Cell Carcinoma

by Newsdesk
Novo Nordisk Acquires Akero Therapeutics for $4.7B, Bolstering Metabolic Disease Pipeline with MASH Treatment post image
M&A Activity pharma-mergers biotech therapeutics

Novo Nordisk Acquires Akero Therapeutics for $4.7B, Bolstering Metabolic Disease Pipeline with MASH Treatment

by Newsdesk
Policy and Funding Headwinds Threaten Boston's Biotech Dominance post image
Industry Trends Digital Health pharma-industry digital-health biotech healthcare-policy healthcare-funding

Policy and Funding Headwinds Threaten Boston's Biotech Dominance

Featured post
by Newsdesk
Novo Nordisk Acquires Akero Therapeutics for $5 Billion to Bolster Liver Disease Pipeline post image
Acquisition pharma-industry M&A Activity pharma-mergers drug-development biotech

Novo Nordisk Acquires Akero Therapeutics for $5 Billion to Bolster Liver Disease Pipeline

Featured post
by Newsdesk
Field Medical Presents Positive 6-Month First-in-Human Data for PFA System in Ventricular Tachycardia post image
clinical-trials Clinical Trials Clinical Trial Results medical-devices regulatory

Field Medical Presents Positive 6-Month First-in-Human Data for PFA System in Ventricular Tachycardia

Featured post
by Newsdesk
Novo Nordisk to Acquire Akero Therapeutics for $4.7 Billion, Bolstering Metabolic and Liver Disease Pipeline post image
Acquisition M&A Activity pharma-mergers biotech drug-development

Novo Nordisk to Acquire Akero Therapeutics for $4.7 Billion, Bolstering Metabolic and Liver Disease Pipeline

by Newsdesk
FDA Grants Fast Track Designation to Adcendo's ADCE-D01 for Soft Tissue Sarcoma Treatment post image
Regulatory Decisions fda-approval oncology clinical-trials

FDA Grants Fast Track Designation to Adcendo's ADCE-D01 for Soft Tissue Sarcoma Treatment

Featured post
by Newsdesk
Global Biotech Hubs: Analyzing the Shifting Landscape and Challenges to Boston's Dominance post image
Industry Trends pharma-industry digital-health biotech healthcare-funding healthcare-policy

Global Biotech Hubs: Analyzing the Shifting Landscape and Challenges to Boston's Dominance

Featured post
by Newsdesk
India's CDSCO Reviews New Drug Approval Process to Foster Fairness and Innovation post image
Regulatory Policy Regulation fda regulatory healthcare-policy drug-development

India's CDSCO Reviews New Drug Approval Process to Foster Fairness and Innovation

Featured post
by Newsdesk
Eli Lilly Commits $1 Billion to Expand India Manufacturing and R&D Capabilities post image
pharma-industry Digital Health Industry Trends pharmaceutical healthcare-funding drug-development

Eli Lilly Commits $1 Billion to Expand India Manufacturing and R&D Capabilities

Featured post
by Newsdesk